TOP TEN perturbations for 38851_at (Homo sapiens)
Organism: Homo sapiens
Gene: 38851_at
Selected probe(set): 207720_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 38851_at (207720_at) across 6674 perturbations tested by GENEVESTIGATOR:
Merkel cell carcinoma study 3 (metastatic) / normal skin tissue
Relative Expression (log2-ratio):-7.4099293Number of Samples:11 / 64
Experimental | Merkel cell carcinoma study 3 (metastatic) |
Metastatic tumor tissue from different metastatic sites (skin, lymph node, parotid gland) of patients with Merkel cell carcinoma of the skin. | |
Control | normal skin tissue |
Normal skin samples from healthy donors. |
wound healing study 2 (ex vivo; DMSO) / normal skin tissue (ex vivo)
Relative Expression (log2-ratio):-7.3371572Number of Samples:3 / 3
Experimental | wound healing study 2 (ex vivo; DMSO) |
Ex vivo skin samples obtained from healthy donors following reduction surgery of abdomen, and incubated in culture medium containing DMSO for 4 days. To make sure that mainly epidermis was present in the samples, as much dermal tissue as possible was removed by dissection. Skin was sliced into 1x10 mm slices and incubated in keratinocyte medium for four days with 1:1000 fold dilution of DMSO. The cultivation was performed in serum-free keratinocyte medium supplemented with transferrin, hEGF (0.15 ng/mL), 0.5 mg/mL hydrocortisone, gentamicin, amphotericin B, and epinephrine but without insulin. | |
Control | normal skin tissue (ex vivo) |
Normal skin samples obtained from healthy donors following reduction surgery of abdomen. To make sure that mainly epidermis was present in the samples, as much dermal tissue as possible was removed by dissection. |
melanoma study 34 (metastatic) / melanoma study 34 (in situ)
Relative Expression (log2-ratio):-6.9496956Number of Samples:40 / 2
Experimental | melanoma study 34 (metastatic) |
Metastatic tumor tissue sample obtained from the patients with metastatic malignant melanoma of the skin. Metastatic samples composed of 22 macroscopic lymph node metastases, 16 subcutaneous metastases and 2 solid organ metastases (adrenal and brain). | |
Control | melanoma study 34 (in situ) |
Tumor tissue from the skin of patients with melanoma in situ. |
melanoma study 34 (metastatic) / normal skin tissue
Relative Expression (log2-ratio):-6.855219Number of Samples:40 / 4
Experimental | melanoma study 34 (metastatic) |
Metastatic tumor tissue sample obtained from the patients with metastatic malignant melanoma of the skin. Metastatic samples composed of 22 macroscopic lymph node metastases, 16 subcutaneous metastases and 2 solid organ metastases (adrenal and brain). | |
Control | normal skin tissue |
Normal skin tissue. |
skin transplantation study 1 (3d) / normal skin tissue (skin grafting)
Relative Expression (log2-ratio):-6.758912Number of Samples:6 / 8
Experimental | skin transplantation study 1 (3d) |
Human skin punch biopsy from patients after skin grafting. Sample was taken at the site of re-epithelialization 3 days after surgery. | |
Control | normal skin tissue (skin grafting) |
Skin biopsy samples from healthy control subjects after breast or abdomen reduction surgery. |
basal cell carcinoma study 3 / normal epidermal keratinocytes
Relative Expression (log2-ratio):6.6812267Number of Samples:4 / 2
Experimental | basal cell carcinoma study 3 |
Primary tumor tissue from the eyelid of patients with basal cell carcinoma (BCC). | |
Control | normal epidermal keratinocytes |
Normal human epidermal keratinocytes (NHEK) (Kurabo Ind., Ltd., Osaka, Japan) cultured in HuMedia-KB2 medium at 37°C in humidified air containing 5% CO2. |
split-thickness skin grafting study 2 (NPWT) / normal skin tissue (skin grafting)
Relative Expression (log2-ratio):-6.5843067Number of Samples:4 / 6
Experimental | split-thickness skin grafting study 2 (NPWT) |
Skin punch biopsy from patients that underwent split-thickness skin grafting. Sample was taken from the wound site 7 days after grafting. Patients received negative-pressure wound therapy (NPWT) immediately after grafting . | |
Control | normal skin tissue (skin grafting) |
Skin punch biopsy samples from healthy patients before slit-thickness skin grafting. |
Merkel cell carcinoma study 3 (primary) / normal skin tissue
Relative Expression (log2-ratio):-6.488268Number of Samples:19 / 64
Experimental | Merkel cell carcinoma study 3 (primary) |
Primary tumor tissue from the skin of patients with Merkel cell carcinoma. | |
Control | normal skin tissue |
Normal skin samples from healthy donors. |
engineered skin substitute study 2 (intermediate) / engineered skin substitute study 1 (intermediate)
Relative Expression (log2-ratio):5.7502575Number of Samples:6 / 3
Experimental | engineered skin substitute study 2 (intermediate) |
Human skin substitutes tissue samples collected after 14 and 28 days after transplantation to athymic mice. | |
Control | engineered skin substitute study 1 (intermediate) |
Human skin substitutes tissue samples collected after 7 days in culture. |
engineered skin substitute study 1 (late) / engineered skin substitute study 1 (early)
Relative Expression (log2-ratio):5.0407457Number of Samples:3 / 2
Experimental | engineered skin substitute study 1 (late) |
Human skin substitutes tissue samples collected after 14 days in culture. | |
Control | engineered skin substitute study 1 (early) |
Human skin substitutes tissue samples collected after 3 days in culture. |